89.3 KPCCMannKind wins long sought FDA approval for insulin inhalerLos Angeles TimesLos Angeles biotech entrepreneur Alfred Mann founded Mannkind, maker of Afrezza. (Kirk McKoy / Los Angeles Times). W.J. Hennigan contact the reporter · Pharmaceutical IndustryMannKind CorporationDiabetesFood and Drug Administration. Los Angeles …UPDATE 3-US FDA approves MannKind’s inhaled insulin, AfrezzaReutersFDA Finally OKs Inhaled InsulinMedPage TodayFDA Approves Inhaled Insulin Afrezza for DiabetesMedscapeWall Street Journal -WebMD -Clinical Endocrinology News Digital Networkall 91 news articles …Read Full Story
MannKind wins long sought FDA approval for insulin inhaler - Los Angeles Times
Real Estate of Cebu
